J. L. Michaux

751 total citations
31 papers, 559 citations indexed

About

J. L. Michaux is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, J. L. Michaux has authored 31 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in J. L. Michaux's work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). J. L. Michaux is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). J. L. Michaux collaborates with scholars based in Belgium, France and Hungary. J. L. Michaux's co-authors include G. Sokal, Augustin Ferrant, A. Louwagie, Herman Van den Berghe, Gregory David, R. L. Verwilghen, Michel Delmée, Bernard Vandercam, V. Avesani and J. Sonnet and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

J. L. Michaux

30 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Michaux Belgium 15 264 157 149 81 77 31 559
G. P. Tauro Australia 15 303 1.1× 132 0.8× 78 0.5× 61 0.8× 254 3.3× 26 711
F Miélot France 13 263 1.0× 163 1.0× 165 1.1× 40 0.5× 75 1.0× 37 674
F. Brito‐Babapulle United Kingdom 12 368 1.4× 111 0.7× 148 1.0× 52 0.6× 97 1.3× 23 630
R Rokicka-Milewska Poland 12 188 0.7× 101 0.6× 59 0.4× 56 0.7× 70 0.9× 55 490
PB McGlave United States 11 602 2.3× 112 0.7× 244 1.6× 180 2.2× 112 1.5× 15 851
Charles Dauriac France 12 251 1.0× 63 0.4× 126 0.8× 176 2.2× 90 1.2× 27 506
C. Costello United Kingdom 12 196 0.7× 53 0.3× 209 1.4× 80 1.0× 44 0.6× 19 510
D Valteau France 13 97 0.4× 91 0.6× 141 0.9× 198 2.4× 52 0.7× 20 497
Carlo Castagnola Italy 16 327 1.2× 132 0.8× 187 1.3× 91 1.1× 91 1.2× 47 574
Walter Feremans Belgium 16 601 2.3× 177 1.1× 338 2.3× 178 2.2× 142 1.8× 58 981

Countries citing papers authored by J. L. Michaux

Since Specialization
Citations

This map shows the geographic impact of J. L. Michaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Michaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Michaux more than expected).

Fields of papers citing papers by J. L. Michaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Michaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Michaux. The network helps show where J. L. Michaux may publish in the future.

Co-authorship network of co-authors of J. L. Michaux

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Michaux. A scholar is included among the top collaborators of J. L. Michaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Michaux. J. L. Michaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neste, Eric Van Den, Philippe Martiat, Philippe Mineur, et al.. (1998). 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia. Annals of Hematology. 76(1). 19–23. 20 indexed citations
2.
Hársfalvi, Jolán, et al.. (1997). Recirculated normal platelets adhere to surfaces coated with plasma from patients with immune thrombocytopenia. Blood Coagulation & Fibrinolysis. 8(1). 59–64. 1 indexed citations
3.
Hermans, Cédric, Nicole Straetmans, J. L. Michaux, & Augustin Ferrant. (1997). Pericarditis induced by high-dose cytosine arabinoside chemotherapy. Annals of Hematology. 75(1-2). 55–57. 27 indexed citations
4.
Mathiot, Claire, Jean–Yves Mary, Éric Tartour, et al.. (1996). Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology. 95(4). 660–665. 7 indexed citations
5.
Façon, Thierry, Jean-François Ménard, J. L. Michaux, et al.. (1995). Prognostic factors in low tumour mass asymptomatic multiple myeloma: A report on 91 patients. American Journal of Hematology. 48(2). 71–75. 28 indexed citations
6.
Michaux, Lucienne, Judith Dierlamm, Iwona Włodarska, et al.. (1995). Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease. British Journal of Haematology. 91(2). 421–424. 23 indexed citations
7.
Delannoy, André, et al.. (1994). 2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukaemia.. PubMed. 36(4). 311–5. 12 indexed citations
8.
Mathiot, Claire, Jean‐Luc Teillaud, Véronique Mosseri, et al.. (1993). Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma. Journal of Clinical Immunology. 13(1). 41–48. 33 indexed citations
9.
Monconduit, M, Jean-François Ménard, J. L. Michaux, et al.. (1992). VAD or VMBCP in severe multiple myeloma. British Journal of Haematology. 80(2). 199–204. 16 indexed citations
10.
Machiels, J.-P., et al.. (1992). A Prospective Randomized Study of Two Alternating, Non Cross-Resistant Chemotherapies For Advanced Hodgkin’s Disease.. Acta Clinica Belgica. 47(4). 244–250. 1 indexed citations
11.
Ferrant, Augustin, Chantal Doyen, André Delannoy, et al.. (1992). High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age. Annals of Hematology. 64(4). 185–189. 2 indexed citations
12.
Straetmans, Nicole, A Ferrant, Philippe Martiat, G. Sokal, & J. L. Michaux. (1992). Le Syndrome Hypereosinophilique (She) A Propos De Deux Cas Et Revue De La Litterature.. Acta Clinica Belgica. 47(2). 90–97. 2 indexed citations
13.
Martiat, Philippe, Augustin Ferrant, Chantal Doyen, et al.. (1990). High‐dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study. European Journal Of Haematology. 45(3). 164–167. 17 indexed citations
14.
Lans, M., et al.. (1988). variations in serum alkaline dnase activity. A new means for therapeutic monitoring of malignant lymphomas. Cancer. 61(9). 1838–1843. 31 indexed citations
15.
Michaux, J. L., et al.. (1980). The Karyotype in Refractory Anaemia and Pre-leukaemia. Clinics in Haematology. 9(1). 129–139. 17 indexed citations
16.
Berghe, Hélène Van Den, A. Louwagie, A. Broeckaert-Van Orshoven, et al.. (1979). Philadelphia Chromosome in Human Multiple Myeloma<xref ref-type="fn" rid="fn2">2</xref>. JNCI Journal of the National Cancer Institute. 63(1). 11–6. 49 indexed citations
17.
Sonnet, J. & J. L. Michaux. (1960). C-réactive protéine et globuline γx chez les bantous du bas-congo. Clinica Chimica Acta. 5(2). 223–229.
18.
Schultze, H. E., G. Schwick, J. Sonnet, J.F. Heremans, & J. L. Michaux. (1960). Gamma-X-Globulin, eine immunoelektrophoretisch nachweisbare ?-Globulin-Komponente mit Beziehungen zum C-Reaktiven Protein. Journal of Molecular Medicine. 38(2). 62–66. 4 indexed citations
19.
20.
Sonnet, J. & J. L. Michaux. (1959). [Considerations on the hyperglobulinemia of the normal Bantu].. PubMed. 39. 495–505. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. P. Tauro Breakdown of academic impact, for papers by F Miélot Breakdown of academic impact, for papers by F. Brito‐Babapulle Breakdown of academic impact, for papers by R Rokicka-Milewska Breakdown of academic impact, for papers by PB McGlave Breakdown of academic impact, for papers by Charles Dauriac Breakdown of academic impact, for papers by C. Costello Breakdown of academic impact, for papers by D Valteau Breakdown of academic impact, for papers by Carlo Castagnola Breakdown of academic impact, for papers by Walter Feremans
Rankless by CCL
2026